hk-ipo/data/extracted_text/01609/allotment_results_2026-05-04_2026050403728.txt

--- page 1 ---
1
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock  Exchange ”)
and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no responsibility for the contents of this
announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability
whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this
announcement.
Unless otherwise defined herein, capitalized terms used in this announcement shall have the same meanings as those
defined in the prospectus dated April 24, 2026 (the “Prospectus ”) of Star Sports Medicine Co., Ltd. (ٰ
ʮ̡ ) (the “Company ”).
This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase
or subscribe for securities. This announcement is not a prospectus. Potential investors should read the Prospectus for
detailed information about the Global Offering described below before deciding whether or not to invest in the Offer
Shares. Any investment decision in relation to the Offer Shares should be taken solely in reliance on the information
provided in the Prospectus.
This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States
(including its territories and possessions, any state of the United States and the District of Columbia). This
announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in
the United States. The securities mentioned herein have not been, and will not be, registered under the United States
Securities Act of 1933, as amended (the “U.S. Securities Act ”). The securities may not be offered or sold in the
United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act and in
compliance with any applicable state securities laws, or outside the United States unless in compliance with Regulation
S under the U.S. Securities Act. There will be no public offer of securities in the United States. The Offer Shares are
being offered and sold outside the United States in offshore transactions in reliance on Regulation S under the U.S.
Securities Act.
The Hong Kong Offer Shares will be offered to the public in Hong Kong subject to terms and conditions set out in
the Prospectus. The Hong Kong Offer Shares will not be offered to any person who is outside Hong Kong and/or not
resident in Hong Kong.
Potential investors of the Offer Shares should note that the Joint Sponsors and the Sponsor-Overall Coordinators (for
themselves and on behalf of the Hong Kong Underwriters) shall, in their sole and absolute discretion, be entitled to
terminate their obligations under the Hong Kong Underwriting Agreement with immediate effect upon the occurrence
of any of the events set out in the paragraph headed “Underwriting {  Underwriting Arrangements and Expenses {
The Hong Kong Public Offering {  Grounds for Termination ” in the Prospectus at any time prior to 8:00 a.m. (Hong
Kong time) on the Listing Date (which is currently expected to be on Tuesday, May 5, 2026).


--- page 2 ---
2
STAR SPORTS MEDICINE CO., LTD.
ʮ̡
(A joint stock company incorporated in the People ’s Republic of China with limited liability)
Global Offering
Number of Offer Shares under the
Global Offering
: 8,421,850 H Shares
Number of Hong Kong Offer Shares: : 842,200 H Shares
Number of International Offer Shares : 7,579,650 H Shares
Offer Price : HK$98.50 per H Share, plus brokerage of
1.0%, SFC transaction levy of 0.0027%,
Hong Kong Stock Exchange trading fee of
0.00565% and AFRC transaction levy of
0.00015%
Nominal value : RMB1.00 per H Share
Stock code : 1609
Joint Sponsors, Overall Coordinators, Joint Global Coordinators,
Joint Bookrunners and Joint Lead Managers
Overall Coordinators, Joint Global Coordinators, Joint Bookrunners
and Joint Lead Managers
Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager
Joint Bookrunners and Joint Lead Managers


--- page 3 ---
3
STAR SPORTS MEDICINE CO., LTD.
ʮ̡
ANNOUNCEMENT OF ALLOTMENT RESULTS
Unless otherwise defined herein, capitalized terms used in this announcement shall have the same
meanings as those defined in the prospectus dated April 24, 2026 (the “Prospectus ”) of Star Sports
Medicine Co., Ltd. (ʮ̡ ) (the “Company ”).
Warning: In view of high concentration of shareholding in a small number of Shareholders,
Shareholders and prospective investors should be aware that the price of the H Shares
could move substantially even with a small number of H Shares traded and should exercise
extreme caution when dealing in the H Shares.
SUMMARY
Company Information
Stock code 1609
Stock short name STAR SPORTS
 MED
Dealings commencement date May 5, 2026*
* see note at the end of the announcement
Price Information
Offer Price HK$98.50
Offer Shares and Share Capital
Number of Offer Shares 8,421,850
Number of Offer Shares in Hong Kong Public Offering 842,200
Number of Offer Shares in International Offering 7,579,650
Number of issued Shares upon Listing 54,831,344


--- page 4 ---
4
Proceeds
Gross proceeds (Note) HK$829.6 million
Less: Estimated listing expenses payable based on Offer Price HK$71.2 million
Net proceeds HK$758.4 million
Note: Gross proceeds refers to the amount which the Company is entitled to receive. For details of the use of proceeds,
please refer to the section headed “Future Plans and Use of Proceeds ” of the Prospectus.
ALLOTMENT RESULTS DETAILS
HONG KONG PUBLIC OFFERING
No. of valid applications 300,735
No. of successful applications 16,844
Subscription level 7,823.13 times
Claw-back triggered N/A
No. of Offer Shares initially available under the Hong Kong
 Public Offering 842,200
No. of Offer Shares reallocated from the International Offering N/A
Final no. of Offer Shares under the Hong Kong Public Offering 842,200
% of Offer Shares under the Hong Kong Public Offering to the
 Global Offering 10.00%
Note: For details of the final allocation of Shares to the Hong Kong Public Offering, investors can refer to the designated
results of allocations website at www.eipo.com.hk/eIPOAllotment  to perform a search by identification number or
the “Allotment Results” page of the White Form eIPO service at www.eipo.com.hk/eIPOAllotment for the full list of
allottees.
INTERNATIONAL OFFERING
No. of placees 71
Subscription Level 10.41 times
No. of Offer Shares initially available under the International Offering 7,579,650
No. of Offer Shares reallocated to the Hong Kong Public Offering N/A
Final no. of Offer Shares under the International Offering 7,579,650
% of Offer Shares under the International Offering to the
 Global Offering 90.00%


--- page 5 ---
5
The Directors confirm that, to the best of their knowledge, information and belief, save for a
waiver from strict compliance with Rule 10.04 of the Listing Rules, consents under paragraph
1C(2) of Appendix F1 to the Listing Rules (the “Placing Guidelines ”) and Chapter 4.15 of the
Guide for New Listing Applicants ( “Listing Guide ”) granted by the Stock Exchange to permit the
Company to, among other things, place certain H Shares in the International Offering to existing
Shareholders and/or their close associates, (i) none of the Offer Shares subscribed by the placees
and the public have been financed directly or indirectly by the Company, any of the Directors,
chief executive of the Company, substantial shareholders, existing shareholders of the Company or
any of its subsidiaries or their respective close associates; (ii) none of the placees and the public
who have purchased the Offer Shares are accustomed to taking instructions from the Company, any
of the Directors, chief executive of the Company, substantial shareholders, existing shareholders
of the Company or any of its subsidiaries or their respective close associates in relation to the
acquisition, disposal, voting or other disposition of Shares registered in his/her/its name or
otherwise held by him/her/it.
The placees in the International Offering include the following:
Cornerstone Investors
Investor
No. of
Offer
Shares
allocated
% of
Offer
Shares
% of total
issued
share
capital
after
the Global
Offering
Existing
shareholders
or their close
associates
JSC International Investment Fund SPC
 ( “JSC International ”) for and on behalf of JSC
 International Investment Fund SPC-Shenghai SP
 ( “Shenghai SP ”)
1,968,550 23.37% 3.59% No
OAP IV (HK) Limited (̬ಂ (ಥ)ʮ̡ )
 ( “OAP IV ”) (Note 1)
397,650 4.72% 0.73% Yes
Greater Bay Area Development Fund Management
 Limited (ʮ̡ )
 ( “GBAD Fund Management ”) for and on behalf of the
 Managed Account of Mega Prime Development Limited
 ( “Mega Prime ”)
318,100 3.78% 0.58% No
GBAD Fund Management for and on behalf of the
 Managed Account of Poly Platinum Enterprises Limited
 ( “Poly Platinum ”)
238,600 2.83% 0.44% No
Note:
1. OAP IV is our existing Shareholder. The Company has applied to the Stock Exchange, and the Stock Exchange
has granted a waiver under Rule 10.04 of the Listing Rules and a consent under paragraph 1C(2) of the Placing
Guidelines in relation to the subscription of the Offer Shares as Cornerstone Investor by OAP IV pursuant to
the anti-dilution right. For further details, please refer to the section headed “Waiver from Strict Compliance
with the Listing Rules {  Waiver under Rule 10.04 and Consent under Paragraph 1C(2) of Appendix F1 to the
Listing Rules in Respect of Subscriptions of Offer Shares by Existing Shareholders as Cornerstone Investors ”
in the Prospectus and the section headed “Allotment Results Details {  International Offering {  Allottees with
waiver/consents obtained ” in this announcement.


--- page 6 ---
6
Allottees with waiver/consents obtained
Investor
No. of
Offer
Shares
allocated
% of
Offer
Shares
% of
total
issued
share
capital
after the
Global
Offering Relationship
Allottees with consent under paragraph 1C(1) of the Placing Guidelines in relation to allocations to
connected clients (Note 1)
China Asset Management (Hong
Kong) Limited
(“China AMC ”)
750 0.01% 0.00% A connected client of CLSA Limited
 ( “CLSA”)
China Galaxy International
Investment Co., Limited
(“CGII”)
397,600 4.72% 0.73% A connected client of China Galaxy
 International Securities (Hong Kong)
 Co., Limited ( “CGIS”)
China Universal Asset
Management (Hong Kong)
Company Limited
(“China Universal (HK) ”)
500 0.01% 0.00% A connected client of Orient Securities
 (Hong Kong) Limited
 ( “Orient Securities ”)
CITIC Securities International
Capital Management Limited
(“CSICM ”)
1,200 0.01% 0.00% A connected client of CLSA
Orient Asset Management
(Hong Kong) Limited
(“Orient AM ”)
4,000 0.05% 0.01% A connected client of Orient Securities
Hong Kong Haicheng Capital
Limited ( “Haicheng Capital ”)
440,300 5.23% 0.80% A connected client of Orient Securities
Allottees with waiver from strict compliance with Rule 10.04 of the Listing Rules and consent under
paragraph 1C(2) of the Placing Guidelines in relation to allocation to existing Shareholders and/or their
close associates as Cornerstone Investors or placees  (Note 2)
CGII 397,600 4.72% 0.73% A close associate of the Existing
 Shareholders  (Note 3)
Haicheng Capital 440,300 5.23% 0.80% A close associate of the Existing
 Shareholders
OAP IV  (Note 4) 397,650 4.72% 0.73% A cornerstone investor and an
 existing Shareholder


--- page 7 ---
7
Notes:
1. For details of the consent under paragraph 1C(1) of the Placing Guidelines in relation to allocations to connected
clients, please refer to the section headed “Additional Information – Placing to connected clients with a prior
consent under paragraph 1C(1) of the Placing Guidelines ” in this announcement.
2. The Stock Exchange has granted a waiver from the strict compliance with Rule 10.04 of the Listing Rules and
a consent under paragraph 1C(2) of the Placing Guidelines to permit Offer Shares to be placed to the above
placee who are close associate of certain existing Shareholders. Please refer to the section headed “Additional
Information – Placing to close associates of existing Shareholders as placees with a waiver from the strict
compliance with Rule 10.04 of the Listing Rules and a prior consent under paragraph 1C(2) of the Placing
Guidelines ” in this announcement.
3. As defined in Note 6 to the section headed “Additional Information – Placing to close associates of existing
Shareholders as placees with a waiver from the strict compliance with Rule 10.04 of the Listing Rules and a
prior consent under paragraph 1C(2) of the Placing Guidelines ” in this announcement. ”
4. As disclosed in the Prospectus, OAP IV, as one of the Pre-IPO Investors, has the right pursuant to the August
2025 Supplemental Agreement to purchase up to the number of ordinary shares of the Company offered in the
Global Offering at the Offer Price that enables it to maintain its ownership interest percentage in the Company
immediately prior to a qualified IPO (the “OAP IV Entitled Shares ”) (the “OAP IV Anti-Dilution Right ”).
In the Global Offering, OAP IV will exercise the OAP IV Anti-Dilution Right to subscribe for additional
Offer Shares at the Offer Price as a cornerstone investor in the International Offering. Following the exercise
of the OAP IV Anti-Dilution Right, OAP IV shall not own more than its percentage shareholding interest in
the Company as at immediately before the Global Offering. The Stock Exchange has granted a waiver from
strict compliance with Rule 10.04 of the Listing Rules, and a consent under paragraph 1C(2) of the Placing
Guidelines, to allow OAP IV to subscribe for Offer Shares in the Global Offering as a cornerstone investor.
Such waiver and consent were granted on the basis that, among other things, (a) the allocation to OAP IV
is necessary in order to give effect to the OAP IV Anti-Dilution Right under the August 2025 Supplemental
Agreement and such allocation will not affect the Company ’s ability to satisfy the public float requirement
under Rule 8.08 of the Listing Rules; (b) full disclosure of the OAP IV Anti-Dilution Right and the number
of shares to be subscribed for by OAP IV will be made in the Prospectus, the allotment results announcement
and the placee lists to be submitted to the Stock Exchange; (c) the OAP IV Entitled Shares will be subscribed
for by OAP IV at the Offer Price and will not result in the percentage interest held by OAP IV in the Company
increasing above the percentage interest held by OAP IV immediately prior to the Global Offering; and (d)
the subscription of the OAP IV Entitled Shares by OAP IV will not have any impact on the Shares to be
offered to the public investors in Hong Kong under the Hong Kong Public Offering, considering that OAP IV
will subscribe for the OAP IV Entitled Shares in the International Offering at the same offer price and under
substantially the same terms and conditions as other cornerstone investors in the Global Offering.


--- page 8 ---
8
LOCK-UP UNDERTAKINGS
Controlling Shareholders
Name
Number of
H Shares
held in the
Company
subject to
lock-up
undertakings
upon Listing
% of total
issued
Shares in
the Company
upon Listing
Last day
subject to the
lock-up
undertakings (Note 1)
Mr. Dong Wenxing (Note 2) 15,382,400 28.05 % May 4, 2027
Tianjin Yunkang Technology Center
(Limited Partnership) (Note 2)
1,900,000 3.47% May 4, 2027
Tianjin Puhe Enterprise Management
Consulting Partnership (Limited
Partnership) (Note 2)
1,094,401 1.99% May 4, 2027
Tianjin Jikang Enterprise Management
Consulting Partnership (Limited
Partnership)  (Note 2)
871,061 1.59% May 4, 2027
Subtotal 19,247,862 35.10%
Notes:
1. The expiry date of the lock-up period shown in the table above is pursuant to the PRC Company Laws. The
required lock-up for the Controlling Shareholders ends on May 4, 2026, being 12 months following the Listing
Date.
2. The general partner of each of Tianjin Jikang, Tianjin Yunkang and Tianjin Puhe is Tianjin Bokang, which
is held as to 99% by Mr. Dong and 1% by Ms. Zhang Di, our Non-Executive Director. Mr. Dong is the sole
limited partner of both Tianjin Jikang and Tianjin Puhe. Tianjin Yunkang is an employee shareholding platform
with 33 limited partners and Tianjin Bokang as its sole general partner, among which Mr. Dong held 64.77%
partnership interest, our executive Director Mr. He Lu, our Supervisors Mr. Xu Jingtao, Mr. Yang Tengfei and
Ms. Wang Yali, and our chief operating officer and deputy general manager Mr. Liu Shaobin, held 5.67%,
1.13%, 1.13%, 0.57% and 2.27% partnership interest, respectively, with the remaining partnership interest held
by our employees or former employees. None of the other limited partners hold 5% or more in Tianjin Yunkang
or served as a Director, Supervisor or senior management of the Company. For further details, see “History,
Development and Corporate Structure {  OUR EMPLOYEE SHAREHOLDING PLATFORM. ”


--- page 9 ---
9
Pre-IPO Investors (as defined in the Prospectus)
Name
Number
of H Shares held
in the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued Shares
in the Company
upon Listing
Last day subject
to the lock-up
undertakings
(Note 1)
Xiamen Defu Yuean Investment
Partnership Enterprise (Limited
Partnership)/τҳ༟Υྫ
Άุ(Υྫ )
4,938,004 9.01% May 4, 2027
Suzhou Junlian Xinkang Venture
Investment (Limited Partnership)/ ᘽψ
ੰ௴ุҳ༟ΥྫΆุ (Υ
ྫ)
4,504,897 8.22% May 4, 2027
BEST ALIVE LIMITED/ʮ̡ 2,503,228 4.57% May 4, 2027
OAP IV (HK) Limited/̬ಂ (࠰
ಥ)ʮ̡
4,306,666 7.85% May 4, 2027
Anji Jintian Dinghao Enterprise
Management Consulting Partnership
(Limited Partnership)/؀
၍ଣፔ༔ΥྫΆุ (Υྫ )
2,276,333 4.15% May 4, 2027
Ningbo Meishan Bonded Port Qianyi
Equity Investment Partnership
Enterprise (Limited Partnership)/ت
ᛆҳ༟ΥྫΆุ
(Υྫ )
2,057,501 3.75% May 4, 2027
Beijing Yahui Jinlin Venture Capital
Partnership (Limited Partnership)/ ̏
ԯඩ౉ᎀᎌ௴ุҳ༟ΥྫΆุ (ࠢ
Υྫ)
1,873,568 3.42% May 4, 2027
Beijing Jianxing Healthcare Industry
Equity Investment Partnership
(Limited Partnership)/ጳᔼᐕ
ᛆҳ༟ΥྫΆุ (Υ
ྫ)
1,405,177 2.56% May 4, 2027
Galaxy Yuanhui Investment Co., Ltd/ ვ
ʮ̡
1,170,980 2.14% May 4, 2027


--- page 10 ---
10
Name
Number
of H Shares held
in the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued Shares
in the Company
upon Listing
Last day subject
to the lock-up
undertakings
(Note 1)
Ningbo Xianda Venture Investment
Partnership Enterprise (Limited
Partnership)/΋༺௴ุҳ༟Υྫ
Άุ(Υྫ )
702,588 1.28% May 4, 2027
Taizhou Sida Venture Capital
Partnership (Limited Partnership)/ ̨
༺௴ุҳ༟ΥྫΆุ (Υྫ )
224,828 0.41% May 4, 2027
Khorgos Dadao Venture Capital Co.,
Ltd./ʮ̡
9,368 0.02% May 4, 2027
Langma No. 61 (Shenzhen)
Entrepreneurship Investment Center
(Limited Partnership)/ီʬɤɓ໮
(ଉέ)௴ุҳ༟ʕː (Υྫ )
351,294 0.64% May 4, 2027
Langma No. 62 (Shenzhen)
Entrepreneurship Investment Center
(Limited Partnership)/ီʬɤɚ໮
(ଉέ)௴ุҳ༟ʕː (Υྫ )
351,294 0.64% May 4, 2027
3W Rivus Fund 485,906 0.89% May 4, 2027
Subtotal 27,161,632 49.54%
Notes:
1. Please see “History, Development and Corporate Structure { Information about our Pre-IPO Investors ” in the
Prospectus for the identities of the Pre-IPO Investors.
2. Pursuant to the applicable PRC law, within the 12 months following the Listing Date, all existing Shareholders
(including the Pre-IPO Investors) are prohibited from disposing of any of the Shares held by them.


--- page 11 ---
11
Cornerstone Investors
Name
Number of
H Shares
held in the
Company
subject to
lock-up
undertakings
upon Listing
% of total
issued
Shares in
the Company
upon Listing
Last day subject
to the lock-up
undertakings
(Note 1)
JSC International for and on behalf of
Shenghai SP
1,968,550 3.59% November 4, 2026
OAP IV 397,650 0.73% November 4, 2026
GBAD Fund Management for and on
behalf of the Managed Account of
Mega Prime
318,100 0.58% November 4, 2026
GBAD Fund Management for and on
behalf of the Managed Account of Poly
Platinum
238,600 0.44% November 4, 2026
Note:
1. Each of the Cornerstone Investors has agreed that it will not, whether directly or indirectly, at any time during
the period of six months from and inclusive of the Listing Date (the “Lock-up Period ”), dispose of any of the
Offer Shares they have purchased pursuant to the relevant Cornerstone Investment Agreements, save for certain
limited circumstances, such as transfers to any of its wholly-owned subsidiaries who will be bound by the same
obligations of such Cornerstone Investor, including the Lock-up Period restriction.


--- page 12 ---
12
PLACEE CONCENTRATION ANALYSIS
Placees
Number of
H Shares
allotted
Allotment
as % of
International
Offering
Allotment
as % of total
Offer Shares
Number of
Shares held
upon Listing
% of total
issued share
capital upon
Listing
Top 1 1,968,550 25.97% 23.37% 1,968,550 3.59%
Top 5 4,408,650 58.16% 52.35% 5,345,434 9.75%
Top 10 6,021,800 79.45% 71.50% 11,265,250 20.55%
Top 25 7,550,850 99.62% 89.66% 12,794,300 23.33%
Note:
* Ranking of placees is based on the number of H Shares allotted to the placees.
H SHARE SHAREHOLDER CONCENTRATION ANALYSIS
H Shareholders
Number of
H Shares
allotted
Allotment
as % of
International
Offering
Allotment
as % of
total Offer
Shares
Number of
H Shares
held upon
Listing
% of total
issued H
Share capital
upon Listing
Top 1 – 0.00% 0.00% 19,247,862 35.10%
Top 5 397,650 5.25% 4.72% 38,174,640 69.62%
Top 10 3,204,100 42.27% 38.05% 47,254,120 86.18%
Top 25 7,033,800 92.80% 83.52% 53,443,294 97.47%
Note:
* Ranking of H Shareholders is based on the number of H Shares held by H Shareholders upon Listing.
SHAREHOLDER CONCENTRATION ANALYSIS
Shareholders
Number of
H Shares
allotted
Allotment
as % of
International
Offering
Allotment
as % of
total Offer
Shares
Number of
H Shares
held upon
Listing
Number of
Shares held
upon Listing
% of total
issued share
capital upon
Listing
Top 1 – 0.00% 0.00% 19,247,862 19,247,862 35.10%
Top 5 397,650 5.25% 4.72% 38,174,640 38,174,640 69.62%
Top 10 3,204,100 42.27% 38.05% 47,254,120 47,254,120 86.18%
Top 25 7,033,800 92.80% 83.52% 53,443,294 53,443,294 97.47%
Note:
* Ranking of Shareholders is based on the number of Shares (of all classes) held by Shareholders upon Listing.


--- page 13 ---
13
BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
Subject to the satisfaction of the conditions set out in the Prospectus, valid applications made by
the public will be conditionally allocated on the basis set out below:
Pool A
Number of
H Shares
applied for
Number
of valid
applications Basis of allocation/ballot
Approximate
percentage
allotted of the
total number
of H Shares
applied for
50 69,002 1,034 out of 69,002 to receive 50 Shares 1.50%
100 33,023 499 out of 33,023 to receive 50 Shares 0.76%
150 7,906 121 out of 7,906 to receive 50 Shares 0.51%
200 8,839 137 out of 8,839 to receive 50 Shares 0.39%
250 6,365 99 out of 6,365 to receive 50 Shares 0.31%
300 4,315 69 out of 4,315 to receive 50 Shares 0.27%
350 2,525 41 out of 2,525 to receive 50 Shares 0.23%
400 3,268 54 out of 3,268 to receive 50 Shares 0.21%
450 2,640 44 out of 2,640 to receive 50 Shares 0.19%
500 14,849 248 out of 14,849 to receive 50 Shares 0.17%
600 3,021 52 out of 3,021 to receive 50 Shares 0.14%
700 2,213 39 out of 2,213 to receive 50 Shares 0.13%
800 2,195 39 out of 2,195 to receive 50 Shares 0.11%
900 3,215 59 out of 3,215 to receive 50 Shares 0.10%
1,000 11,642 218 out of 11,642 to receive 50 Shares 0.09%
1,500 5,867 119 out of 5,867 to receive 50 Shares 0.07%
2,000 5,426 118 out of 5,426 to receive 50 Shares 0.05%
2,500 4,462 104 out of 4,462 to receive 50 Shares 0.05%
3,000 3,995 99 out of 3,995 to receive 50 Shares 0.04%
3,500 2,804 74 out of 2,804 to receive 50 Shares 0.04%
4,000 2,715 76 out of 2,715 to receive 50 Shares 0.03%
4,500 2,348 69 out of 2,348 to receive 50 Shares 0.03%
5,000 15,606 483 out of 15,606 to receive 50 Shares 0.03%
10,000 10,525 481 out of 10,525 to receive 50 Shares 0.02%
15,000 6,565 397 out of 6,565 to receive 50 Shares 0.02%
20,000 5,554 417 out of 5,554 to receive 50 Shares 0.02%
25,000 4,436 399 out of 4,436 to receive 50 Shares 0.02%
30,000 3,881 406 out of 3,881 to receive 50 Shares 0.02%
35,000 2,806 338 out of 2,806 to receive 50 Shares 0.02%
40,000 2,677 369 out of 2,677 to receive 50 Shares 0.02%
45,000 2,145 332 out of 2,145 to receive 50 Shares 0.02%
50,000 8,074 1,388 out of 8,074 to receive 50 Shares 0.02%
264,904 Total number of Pool A successful applicants: 8,422


--- page 14 ---
14
Pool B
Number of
H Shares
applied for
Number
of valid
applications Basis of allocation/ballot
Approximate
percentage
allotted of the
total number
of H Shares
applied for
60,000 8,471 1,291 out of 8,471 to receive 50 Shares 0.01%
70,000 3,525 567 out of 3,525 to receive 50 Shares 0.01%
80,000 2,918 493 out of 2,918 to receive 50 Shares 0.01%
90,000 2,074 368 out of 2,074 to receive 50 Shares 0.01%
100,000 6,323 1,174 out of 6,323 to receive 50 Shares 0.01%
150,000 3,699 839 out of 3,699 to receive 50 Shares 0.01%
200,000 2,196 589 out of 2,196 to receive 50 Shares 0.01%
250,000 1,528 505 out of 1,528 to receive 50 Shares 0.01%
300,000 1,045 415 out of 1,045 to receive 50 Shares 0.01%
350,000 807 375 out of 807 to receive 50 Shares 0.01%
421,100 3,245 1,806 out of 3,245 to receive 50 Shares 0.01%
35,831 Total number of Pool B successful applicants: 8,422
As of the date of this announcement, the relevant subscription monies previously deposited in the
designated nominee accounts have been remitted back to the accounts of all HKSCC participants.
Investors should contact their relevant brokers for any inquiries.
ADDITIONAL INFORMATION
Placing to connected clients with a prior consent under paragraph 1C(1) of the Placing
Guidelines
Under the International Offering, certain Offer Shares were placed to connected clients of certain
distributors pursuant to the Placing Guidelines. Details of the placement to connected clients are
set out below.
Connected
client Connected distributor Relationship
Whether the
connected client will
hold beneficial
interests of Offer
Shares on a non-
discretionary
or discretionary
basis for independent
third parties
No. of Offer
Shares
allocated
to the
connected
client
% of Offer
Shares
% of total
issued share
capital after
the Global
Offering
China AMC CLSA Limited ( “CLSA”),
Futu Securities International
(Hong Kong) Limited
(“Futu Securities ”)
See Note 1 Discretionary basis 750 0.01% 0.00%
CGII China Galaxy International
Securities (Hong Kong) Co.,
Limited ( “CGIS”)
See Note 2 Non-discretionary basis 397,600 4.72% 0.73%


--- page 15 ---
15
Connected
client Connected distributor Relationship
Whether the
connected client will
hold beneficial
interests of Offer
Shares on a non-
discretionary
or discretionary
basis for independent
third parties
No. of Offer
Shares
allocated
to the
connected
client
% of Offer
Shares
% of total
issued share
capital after
the Global
Offering
China Universal
 (HK)
Orient Securities (Hong
Kong) Limited ( “Orient
Securities ”)
See Note 3 Discretionary basis 500 0.01% 0.00%
CSICM CLSA See Note 4 Non-discretionary basis 1,200 0.01% 0.00%
Orient AM Orient Securities See Note 5 Discretionary basis 4,000 0.05% 0.01%
Haicheng Capital Orient Securities See Note 6 Discretionary basis 440,300 5.23% 0.80%
Notes:
1. China AMC is a member of the same group of companies as CLSA, China AMC will hold the Offer Shares in
its capacity as discretionary fund manager managing assets on behalf of its underlying clients. To the best of
China AMC ’s knowledge after due enquiry, each underlying client of China AMC is an independent third party
of China AMC, CLSA and the companies which are members of the same group of CLSA; Futu Securities is an
ultimate beneficial owner of a fund managed by China AMC.
2. CGII and China Galaxy Securities ( “CGS”) will enter into a series of cross border total return swap (TRS)
transactions (collectively, the “CGII TRS ”) with each other and the ultimate client ( “CGII Ultimate Client ”),
pursuant to which CGII will hold the Offer Shares on a non-discretionary basis to hedge the CGII TRS while
the economic risks and returns of the underlying Offer Shares are ultimately borne by the CGII Ultimate Client,
subject to customary fees and commissions. The CGII TRS will be fully funded by the CGII Ultimate Client.
During the terms of the CGII TRS, all economic returns of the Offer Shares subscribed by CGII will be passed
to CGII Ultimate Client and all economic loss shall be borne by CGII Ultimate Client through the CGII TRS,
and CGII will not take part in any economic return or bear any economic loss in relation to the Offer Shares.
The CGII Ultimate Client may exercise an early termination right to terminate the CGII TRS at any time from
the issue date of the CGII TRS which should be on or after the date on which the Offer Shares are listed on
the Stock Exchange. Upon the termination upon maturity or early termination of the CGII TRS by the CGII
Ultimate Client, CGII will dispose of the Offer Shares on the secondary market and the CGII Ultimate Client
will receive final settlement amount of the back-to-back TRS which should have taken into account all the
economic returns or economic loss in relation to the Offer Shares. If upon the maturity of the CGII TRS, the
CGII Ultimate Client intends to extend the investment period, subject to further agreement between CGII and
the CGII Ultimate Client, the term of the CGII TRS could be extended by way of a new issuance or a tenor
extension. Accordingly, CGII will extend the term of the back-to-back TRS by way of a new issuance or a tenor
extension.
It is proposed that CGII will hold the legal title and the voting right of the Offer Shares by itself, and pass
through the economic exposure to the CGII Ultimate Client, which place CGII TRS orders through their asset
manager with CGII in connection with the IPO of the Company. Due to its internal policy, CGII will not
exercise the voting right of the Offer Shares during the tenor of the back-to-back TRS.
During the life of the CGII TRS and back-to-back TRS, CGII may continue to hold the Offer Shares in its
custodian account, or to hold some or all of the Offer Shares in a prime brokerage account for stock borrowing
purposes.


--- page 16 ---
16
As permitted under the contractual arrangement with the CGII Ultimate Client, CGII will lend out its holding
of underlying Offer Shares in the form of stock borrowing loans consistent with market practice to lower its
finance costs, provided that CGII has the ability to call back the Offer Shares on loan at any time in order to
satisfy its obligations under the back-to-back TRS to ensure the economic interests to be passed to the CGII
Ultimate Client under the CGII TRS will remain unchanged.
To the best of CGII ’s knowledge after having made all reasonable inquiries, the CGII Ultimate Client is an
independent third party of CGII, and the companies which are members of the same group of CGIS.
Both CGII and CGIS are indirect wholly-owned subsidiaries of CGS, the A shares of which are listed on the
Shanghai Stock Exchange (stock code: 601881), the H shares of which are listed on the Stock Exchange (stock
code: 6881). CGII is a connected client (as defined under Appendix F1 to the Listing Rules) of CGIS, holding
securities on a non-discretionary basis on behalf of independent third parties.
The CGII Ultimate Client is Hangzhou Haida Bicheng Venture Capital Management Partnership(L.P.) (ψऎ
༺̀ϓ௴ุҳ༟၍ଣΥྫΆุ (Υྫ )) ( “Haida Bicheng ”), a limited partnership established in the PRC,
whose general partner is Wang Wengang (࡝“( ) Mr. Wang ”), who owns 41% of the interest of Haida
Bicheng.
3. China Universal (HK) is a member of the same group of companies as Orient Securities. China Universal
(HK) will hold the Offer Shares in its capacity as discretionary fund manager managing assets on behalf of
its underlying clients. To the best of China Universal (HK) ’s knowledge after due enquiry, certain underlying
clients of China Universal (HK) have ultimate beneficial owners holding 30% or more interest of the respective
discretionary fund, however each underlying client of China Universal (HK) is an independent third party of
China Universal (HK), Orient Securities and the companies which are members of the same group of Orient
Securities.
4. CITIC Securities Company Limited ( “CITIC Securities ”), the shares of which are listed on both the Shanghai
Stock Exchange (stock code: 600030) and the Stock Exchange (stock code: 6030), is one of the domestic
securities firms licensed to undertake cross-border derivatives trading activities. CITIC Securities entered into
an International Swaps and Derivatives Association agreement (the “ISDA Agreement ”) with its indirectly
wholly-owned subsidiary, CSICM to set out the principal terms of any future total return swap between CITIC
Securities and CSICM.
CLSA is a sponsor-overall coordinator of the Global Offering. Pursuant to the ISDA Agreement, CSICM, which
intends to participate in the Global Offering as a placee, will hold the Offer Shares on a non-discretionary basis
as the single underlying holder under a back-to-back total return swap (the “Back-to-back TRS ”) to be entered
by CSICM with CITIC Securities in connection with Client TRS (as defined below) placed by and fully funded
(i.e. with no financing provided by CSICM) by the CSICM Ultimate Clients (as defined below), pursuant to
which CSICM will pass the full economic exposure of the Offer Shares to the CSICM Ultimate Clients, which
in effect, CSICM will hold the beneficial interest of the Offer Shares on behalf of the CSICM Ultimate Clients.
Pursuant to the Cross-border Derivatives Trading Regime, the onshore investors (the “CSICM Ultimate
Clients ”) cannot directly subscribe for the Offer Shares but may invest in derivative products issued by domestic
securities firms licenced to undertake cross-border derivatives trading activities, such as CITIC Securities,
with the Offer Shares as the underlying assets. Instead of directly subscribing for the Offer Shares, the CSICM
Ultimate Clients will place a total return swap order (the “Client TRS ”) with CITIC Securities in connection
with the Company ’s IPO and CITIC Securities will place Back-to-back TRS orders to CSICM on the terms of
the ISDA Agreement. In order to hedge its exposure under the Back-to-back TRS, CSICM participates in the
Company ’s IPO and subscribes the Offer Shares through placing order with CLSA during the International
Offering.


--- page 17 ---
17
The following table sets forth the ultimate beneficial owners of CSICM:
Name (CSICM Ultimate Client) Asset Manager
UBO of Asset
Manager
UBO of CSICM
Ultimate Client
Yucheng Xiangjiang Qiming Private Securities Investment
Fund* (ږ)
Yucheng Private Fund Management (Hainan) Partnership
(Limited Partnership)* (၍ଣ (ی)ΥྫΆุ
(Υྫ )) ( “Yucheng ”)
Ma Shuying ( ৵Ꮳᆦ) Li Jianxue (ኪ)
Liangpai Exclusive Fund No. 43 Private Securities Investment
Fund* (ږ)
Shanghai QuantPi Investment Limited (ࠢ
ʮ̡) (“Shanghai Liangpai ”)
Sun Lin (؍࢑Yu
Hang ( ቱঘ)
Sun Lin (؍࢑)
Evolution Darwin Zenshan No. 3 Private Securities Investment
Fund* (ږ)
Evolution Asset Management co., Ltd. (၍
ʮ̡ ) (“Hainan Evolution ”)
Wang Yiping ( ˮɓ̻) N/A1
Tongyi Taoli No. 1 Private Securities Investment Fund* (׋
ҽ 1 ږ)
Shanghai Tongyi Investment Management Co., Ltd. (ҳ
ʮ̡ ) (“Shanghai Tongyi ”)
Chu Yibo (تWang Jing ( ˮ᎑)
Tongyi Taoli No. 10 Private Securities Investment Fund* ( ஷ
ҽ 10 ږ)
Shanghai Tongyi Investment Management Co., Ltd. (ҳ
ʮ̡ )
Chu Yibo (تN/A2
To the best knowledge of CSICM after making all reasonable enquiries, the CSICM Ultimate Clients are
independent third parties of CSICM and CLSA, the companies which are members of the same group of
companies as CLSA and the Company.
Pursuant to the terms of the contracts of the Back-to-back TRS and the Client TRS, during the tenor of the
Back-to-back TRS and the Client TRS, all economic returns of the Offer Shares will be passed to the CSICM
Ultimate Clients through the Back-to-back TRS and the Client TRS and all economic loss shall be borne by the
CSICM Ultimate Clients. CSICM and CITIC Securities will not take any economic return or bear any economic
loss in relation to the Offer Shares.
The CSICM Ultimate Clients may exercise an early termination right to terminate the Client TRS at any time
from the issue date of the Client TRS which should be on or after the date on which the Offer Shares are listed
on the Stock Exchange. Upon the termination upon maturity or early termination of the Client TRS by the
CSICM Ultimate Clients, CSICM will dispose of the Offer Shares on the secondary market and the CSICM
Ultimate Clients will receive final settlement amount of the Back-to-back TRS which should have taken into
account all the economic returns or economic loss in relation to the Offer Shares. If upon the maturity of the
Client TRS, the CSICM Ultimate Clients intend to extend the investment period, subject to further agreement
between CSICM and the CSICM Ultimate Clients, the term of the Client TRS could be extended by way of a
new issuance or a tenor extension. Accordingly, CSICM will extend the term of the Back-to-back TRS by way
of a new issuance or a tenor extension.
It is proposed that CSICM will hold the legal title and the voting right of the Offer Shares by itself, and pass
through the economic exposure to the CSICM Ultimate Clients, which place Client TRS orders through their
asset manager with CITIC Securities in connection with the IPO of the Company. Due to its internal policy,
CSICM will not exercise the voting right of the Offer Shares during the tenor of the Back-to-back TRS.
During the life of the Client TRS and Back-to-back TRS, CSICM may continue to hold the Offer Shares in its
custodian account, or to hold some or all of the Offer Shares in a prime brokerage account for stock borrowing
purposes.
As permitted under the contractual arrangement with the CSICM Ultimate Clients, CSICM will lend out its
holding of underlying Offer Shares in the form of stock borrowing loans consistent with market practice to
lower its finance costs, provided that CSICM has the ability to call back the Offer Shares on loan at any time in
order to satisfy its obligations under the Back-to-back TRS to ensure the economic interests to be passed to the
CSICM Ultimate Clients under the Client TRS will remain unchanged.
1 No ultimate beneficial owners holding 30% or more interest
2 No ultimate beneficial owners holding 30% or more interest


--- page 18 ---
18
5. Orient AM will hold the Offer Shares in its capacity as discretionary fund manager managing assets on behalf of
its underlying clients under the sub-funds, namely OSR Selective No.4 and OSR Voyage No.16. Orient AM is a
member of the same group of companies as Orient Securities. To the best of Orient AM ’s knowledge after due
enquiry, each underlying client of Orient AM is an independent third party of Orient AM, Orient Securities and
the companies which are members of the same group of Orient Securities.
6. Haicheng Capital ’s securities account has been fully entrusted to Orient AM for management, and Orient AM
has been granted all investment and trading authority over Haicheng Capital ’s account. Orient AM is a member
of the same group of companies as Orient Securities. Haicheng Capital ’s ultimate beneficiary owners are Chen
Qiao ( ௓̷) and Wang Wengang (࡝“( ) Mr. Wang ”), who owns 41% and 40% of the issued capital of
Haicheng Capital as of the date of this application.
Ningbo Xianda Venture Investment Partnership Enterprise (Limited Partnership) (΋༺௴ุҳ༟ΥྫΆุ
(Υྫ )) ( “Ningbo Xianda ”) is a limited partnership incorporated in the PRC on June 29, 2021. Taizhou
Sida Venture Capital Partnership (Limited Partnership) (༺௴ุҳ༟ΥྫΆุ (Υྫ )) ( “Taizhou
Sida”) is a limited partnership incorporated in the PRC on March 2, 2022. Khorgos Dadao Venture Capital Co.,
Ltd. (ʮ̡ ) ( “Khorgos Dadao ”) is a limited liability company established in the
PRC on February 28, 2017. The general partner of Ningbo Xianda and the sole shareholder of Khorgos Dadao
is Tianjin Haida Venture Capital Management Co., Ltd. (ʮ̡ ) ( “Tianjin Haida ”),
which is ultimately controlled by Mr. Wang, an Independent Third Party of the Company. The general partner
of Taizhou Sida is Hangzhou Haida Bicheng Venture Capital Management Partnership(L.P.) (ψऎ༺̀ϓ
௴ุҳ༟၍ଣΥྫΆุ (Υྫ )) ( “Haida Bicheng ”), a limited partnership established in the PRC, whose
general partner is Mr. Wang, who owns 41% of the interest of Haida Bicheng. Accordingly, each of Ningbo
Xianda, Taizhou Sida and Khorgos Dadao is under the common control of Mr. Wang (together as the “Existing
Shareholders ”). Haida Bicheng, being a company of which Mr. Wang is an ultimate beneficiary owner holding
40% of its issued capital, and Mr. Wang controlling each of the Existing Shareholders, is a close associate of
the Existing Shareholders. None of the limited partners holds 30% or more of limited partnership interests in
either of Ningbo Xianda, Taizhou Sida and Haida Bicheng.
As of the Latest Practicable Date (as defined in the Prospectus), Ningbo Xianda, Taizhou Sida and Khorgos
Dadao held 1.51%, 0.48% and 0.02% of the total issued shares capital of the Company.
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, a
consent under paragraphs 1C(1) of the Placing Guidelines to permit the Company to allocate such
Offer Shares in the International Offering to the connected clients listed above. The allocation of
Offer Shares to such connected clients is in compliance with all the conditions under the consent
granted by the Stock Exchange.
Placing to close associates of existing Shareholders as placees with a waiver from the strict
compliance with Rule 10.04 of the Listing Rules and a prior consent under paragraph 1C(2)
of the Placing Guidelines
The Company has applied to the Stock Exchange, and the Stock Exchange has granted, the waivers
from the strict compliance with Rule 10.04 of the Listing Rules and consents under paragraph
1C(2) of the Placing Guidelines to permit the Company to allocate such Offer Shares in the
International Offering to close associates (the “Placees ”) of Existing Shareholders (as defined
below) on the following grounds which are consistent with the conditions as set out in the Chapter
4.15 of the Guide for New Listing Applicant:
(a) the Joint Sponsors confirm that:
(i) each of the Existing Shareholders is interested in less than 5% of the Company ’s voting
rights before the Listing;
(ii) none of the Existing Shareholders or their close associates is a core connected person of
the Company or its close associate;


--- page 19 ---
19
(iii) none of the Existing Shareholders or their close associates has the power to appoint any
Directors to the Board or any other special rights upon the Listing;
(iv) as none of the Existing Shareholders or their close associates is a core connected
person of the Company or its close associate, allocation to the Placees will not affect
the Company ’s ability to satisfy the public float requirement under Rule 8.08(1) (as
amended and replaced by 19A.13A(1) for PRC issuers with no other listed shares) of
the Listing Rules; and
(v) to the best of their knowledge and belief, no preferential treatment has been, nor
will be, given to the Existing Shareholders or their close associates by virtue of their
relationship with the Company in any allocation in the placing tranche;
(b) the Company confirms that no preferential treatment has been, nor will be, given to the
Existing Shareholders or their close associates by virtue of their relationship with the
Company in any allocation of the placing tranche;
(c) the Overall Coordinators confirm that, to the best of their knowledge and belief, no
preferential treatment has been, nor will be, given to the Existing Shareholders or their close
associates by virtue of their relationship with the Company in any allocation in the placing
tranche; and
(d) details of the allocation of H Shares to the Existing Shareholders and their close associates
will be disclosed in this allotment results announcement.
The allocation of Offer Shares to such Existing Shareholders and/or close associates of the Existing
Shareholders is in compliance with all the conditions under the waivers/consents granted by the
Stock Exchange.
For details of the allocation of Offer Shares to a close associate of the Existing Shareholders,
please refer to the section headed “Allotment Results Details {  International Offering {  Allottees
with waiver/consents obtained ” in this announcement.
COMPLIANCE WITH LISTING RULES AND GUIDANCE
The Directors confirm that, except for the Listing Rules that have been waived and/or in respect of
which consent has been obtained, the Company has complied with the Listing Rules and guidance
materials in relation to the placing, allotment and listing of the Company ’s shares.
The Directors confirm that, to the best of their knowledge, the consideration paid by the placees
or the public (as the case may be) directly or indirectly for each Offer Share subscribed for or
purchased by them was the same as the final Offer Price in addition to any brokerage, AFRC
transaction levy, SFC transaction levy and trading fee payable.


--- page 20 ---
20
DISCLAIMERS
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the
“Stock Exchange ”) and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no
responsibility for the contents of this announcement, make no representation as to its accuracy
or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
This announcement is not for release, publication, distribution, directly or indirectly, in or into
the United States (including its territories and possessions, any state of the United States and
the District of Columbia). This announcement does not constitute or form a part of any offer or
solicitation to purchase or subscribe for securities in the United States. The securities mentioned
herein have not been, and will not be, registered under the United States Securities Act of 1933,
as amended (the “U.S. Securities Act ”). The securities may not be offered or sold in the United
States except pursuant to an exemption from the registration requirements of the U.S. Securities
Act and in compliance with any applicable state securities laws, or outside the United States
unless in compliance with Regulation S under the U.S. Securities Act. There will be no public
offer of securities in the United States.
The Offer Shares are being offered and sold outside the United States in offshore transactions in
reliance on Regulation S under the U.S. Securities Act.
This announcement is for information purposes only and does not constitute an invitation or offer
to acquire, purchase or subscribe for securities. This announcement is not a prospectus. Potential
investors should read the Prospectus dated April 24, 2026 issued by Star Sports Medicine Co.,
Ltd. (ʮ̡ ) for detailed information about the Global Offering described
herein before deciding whether or not to invest in the Shares thereby being offered.
* Potential investors of the Offer Shares should note that the Joint Sponsors and the Sponsor-
Overall Coordinators (for themselves and on behalf of the Hong Kong Underwriters) shall,
in their sole and absolute discretion, be entitled to terminate their obligations under the
Hong Kong Underwriting Agreement with immediate effect upon the occurrence of any of
the events set out in the paragraph headed “Underwriting {  Underwriting Arrangements
and Expenses {  The Hong Kong Public Offering {  Grounds for Termination ” in the
Prospectus at any time prior to 8:00 a.m. (Hong Kong time) on the Listing Date (which is
currently expected to be on Tuesday, May 5, 2026).


--- page 21 ---
21
PUBLIC FLOAT AND FREE FLOAT
Immediately following the completion of the Global Offering, (i) approximately 52.12% of the
total number of issued Shares will be regarded as public float and the Company will satisfy the
minimum percentage as prescribed under Rule 19A.13A(1) of the Listing Rules; (ii) the three
largest public Shareholders do not hold more than 50% of the H Shares in public hands at the time
of Listing in compliance with Rules 8.08(3) and 8.24 of the Listing Rules; (iii) there will not be
any new substantial shareholder (as defined in the Listing Rules) of the Company immediately after
the Global Offering; (iv) no placee will, individually, be placed more than 10% of the enlarged
issued share capital of the Company immediately after the Global Offering; and (v) there will be at
least 300 Shareholders at the time of Listing in compliance with Rule 8.08(2) of the Listing Rules.
In consideration that the total number of H Shares in issue upon Listing that are held by the public
and not subject to any disposal restrictions is expected to be at least 10% of the total issued share
capital of the Company, the Company is expected to satisfy the free float requirement under Rule
19A.13C of the Listing Rules at the time of Listing.
COMMENCEMENT OF DEALINGS
The H Share certificates will only become valid evidence of title at 8:00 a.m. (Hong Kong time) on
Tuesday, May 5, 2026, provided that the Global Offering has become unconditional and the right
of termination described in the section headed “Underwriting {  Underwriting Arrangements and
Expenses { The Hong Kong Public Offering {  Grounds for Termination ” in the Prospectus has
not been exercised. Investors who trade H Shares prior to the receipt of H Share certificates or the
H Share certificates becoming valid evidence of title do so entirely at their own risk.
Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. (Hong Kong
time) on Tuesday, May 5, 2026, it is expected that dealings in the H Shares on the Stock Exchange
will commence at 9:00 a.m. on Tuesday, May 5, 2026. The H Shares will be traded in board lots of
50 H Shares each. The stock code of the Shares is 1609.
By order of the Board
Star Sports Medicine Co., Ltd.
Mr. Dong Wenxing
Chairman of the Board and Executive Director
Hong Kong, May 4, 2026
As at the date of this announcement, the Board comprises: (i) Mr. Dong Wenxing and Mr. He Lu
as executive directors; (ii) Ms. Zhang Di, Mr. Chang Xi, Mr. David Guowei Wang, Ms. Yi Lin and
Mr. Zhou Quan as non-executive directors and (iii) Mr. Lyu Zhenlin, Mr. Deng Yu, Mr. Liu Baojie
and Mr. Wang Chunfei as independent non-executive directors.